ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,538Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1383

$685K Total Retail Price of All Prescriptions

Rank: 173 out of 1383

818 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 818 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

5% of this provider’s 13,451 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 811 391 S3 1 1
ATENOLOL 678 528 2 16
LISINOPRIL 613 388 3 3
SIMVASTATIN 605 406 4 2
LEVOTHYROXINE SODIUM 572 455 5 4
TRAMADOL HCL 568 392 6 25
FUROSEMIDE 566 476 7 7
ATENOLOL-CHLORTHALIDONE 550 409 10 8 149
OMEPRAZOLE 480 343 9 5
GLYBURIDE 449 339 R 10 46
METFORMIN HCL ER 396 302 11 47
POTASSIUM CHLORIDE 382 303 12 12
METFORMIN HCL 355 267 13 8
METOPROLOL TARTRATE 332 259 14 9
RANITIDINE HCL 289 187 15 19
TRIAMTERENE-HYDROCHLOROTHIAZID 281 221 10 16 154
AMLODIPINE BESYLATE 270 222 17 6
WARFARIN SODIUM 247 153 18 13
ZOLPIDEM TARTRATE 240 162 19 17
MELOXICAM 239 181 20 20
TAMSULOSIN HCL 233 219 21 30
BENAZEPRIL HCL 186 155 22 38
PROAIR HFA 178 94 23 42
NEXIUM 176 129 24 26
GABAPENTIN 159 66 25 11
METOPROLOL SUCCINATE 156 118 26 29
PREDNISONE 151 98 27 40
CITALOPRAM HBR 147 95 28 15
AZITHROMYCIN 138 99 29 41
FLUTICASONE PROPIONATE 135 103 30 39
DILTIAZEM 24HR CD 134 114 31 95
PANTOPRAZOLE SODIUM 129 96 32 32
GEMFIBROZIL 127 62 33 90
DOXYCYCLINE HYCLATE 126 101 34 94
TRAZODONE HCL 126 112 34 36
METHOCARBAMOL 124 62 R 36 141
HYDROCHLOROTHIAZIDE 120 76 37 10
INDAPAMIDE 117 101 38 153
ESTRADIOL 112 75 R 39 96
DIGOXIN 109 88 40 59
SPIRIVA 105 80 41 45
DONEPEZIL HCL 105 105 41 35
ALLOPURINOL 105 79 41 33
CLONIDINE HCL 97 65 44 44
INSULIN SYRINGE 95 76 45 83
POLYETHYLENE GLYCOL 3350 94 83 46 64
CLOPIDOGREL 94 82 46 28
PLAVIX 94 81 46 43
FLUOXETINE HCL 93 27 49 52
PRAVASTATIN SODIUM 93 76 49 14
LOVASTATIN 91 65 51 22
SYNTHROID 91 73 51 73
SPIRONOLACTONE 89 81 53 67
PREMARIN 84 68 R 54 123
ATORVASTATIN CALCIUM 84 71 54 18
MECLIZINE HCL 83 61 56 113
ALENDRONATE SODIUM 82 64 57 37
LYRICA 80 55 58 72
NAPROXEN 79 46 59 105
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 56 60 27
ENALAPRIL MALEATE 74 74 61 75
ADVAIR DISKUS 74 69 61 63
PAROXETINE HCL 70 0 63 55
IBUPROFEN 66 45 64 91
PROMETHAZINE HCL 66 16 R 64 56
CRESTOR 63 44 66 34
TRIAMTERENE-HCTZ 62 43 67 48
SERTRALINE HCL 62 44 67 21
ACETAMINOPHEN-CODEINE 62 32 S3 67 163
GLYBURIDE MICRONIZED 60 51 R 70 209
CEPHALEXIN 59 36 71 87
CARVEDILOL 58 45 72 24
CLOTRIMAZOLE-BETAMETHASONE 56 42 73 205
DIOVAN 56 38 73 58
CELEBREX 56 56 73 131
COMBIVENT 55 44 76 116
VENTOLIN HFA 54 40 77 93
NOVOLOG MIX 70-30 54 54 77 273
NYSTATIN-TRIAMCINOLONE 53 45 79 275
CIPROFLOXACIN HCL 52 47 80 54
BUMETANIDE 52 48 80 122
CYCLOBENZAPRINE HCL 52 18 R 80 69
ISOSORBIDE MONONITRATE ER 51 44 83 66
VERAPAMIL ER 50 50 84 84
BETAMETHASONE VALERATE 50 38 84 451
NABUMETONE 50 38 84 156
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.